Sichuan Kelun-Biotech Biopharmaceutical Co (HKSE:06990) EV-to-FCF : -216.26 (As of May. 14, 2024)

Sichuan Kelun-Biotech Biopharmaceutical Co EV-to-FCF Chart

Competitive Comparison of Sichuan Kelun-Biotech Biopharmaceutical Co's EV-to-FCF

For the Biotechnology subindustry, Sichuan Kelun-Biotech Biopharmaceutical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sichuan Kelun-Biotech Biopharmaceutical Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sichuan Kelun-Biotech Biopharmaceutical Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Sichuan Kelun-Biotech Biopharmaceutical Co's EV-to-FCF falls into.

Sichuan Kelun-Biotech Biopharmaceutical Co EV-to-FCF Calculation

Sichuan Kelun-Biotech Biopharmaceutical Co's EV-to-FCF for today is calculated as:

Sichuan Kelun-Biotech Biopharmaceutical Co's current Enterprise Value is HK$35,164.2 Mil.
Sichuan Kelun-Biotech Biopharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-162.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sichuan Kelun-Biotech Biopharmaceutical Co  (HKSE:06990) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Sichuan Kelun-Biotech Biopharmaceutical Co's PE Ratio for today is calculated as:

Sichuan Kelun-Biotech Biopharmaceutical Co's share price for today is HK$175.70.
Sichuan Kelun-Biotech Biopharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-1.593.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Sichuan Kelun-Biotech Biopharmaceutical Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Sichuan Kelun-Biotech Biopharmaceutical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Sichuan Kelun-Biotech Biopharmaceutical Co (HKSE:06990) Business Description